Source: International Congress 2018 – Important changes in the management of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Bothamley (London, United Kingdom). Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)?. International Congress 2018 – Important changes in the management of tuberculosis

Member's Comments

No comment yet.

Related content which might interest you: Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Poor agreement between whole-blood IFN-? assay and TST for the diagnosis of latent TB infection in children Source: ISSN=ISSN 1810-6838, ISBN=, page=378 Year: 2007 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Interferon-γ released assay (IGRA) in Greek patients with sarcoidosis Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Do higher quantitative interferon gamma release assay or tuberculin skin test results help to predict incident tuberculosis? Data from the UK PREDICT study Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I Year: 2019